<p><strong>史密斯与纳菲 SNATS, Inc.</strong> (NYSE:SNN - 获取免费报告) 于 3 月 5 日（星期四）宣布派发股息。3 月 27 日（星期五）登记在册的股东将于 5 月 27 日（星期三）获得每股 0.482 的股息。这代表着 281.0% 的股息收益率。除息日期为 3 月 27 日（星期五）。</p>
<p>获取 <strong>史密斯与纳菲 SNATS</strong> 的提醒：</p>
<ul>
<li>圣诞行情提前到来，这些股票受益</li>
</ul>
<p>史密斯与纳菲 SNATS 在过去三年中平均每年提高股息支付 0.0%。史密斯与纳菲 SNATS 的派息比率为 26.0%，表明其股息得到了足够的盈利支持。研究分析师预计史密斯与纳菲 SNATS 明年的每股收益为 2.00 美元，这意味着公司应该能够继续覆盖其 0.57 美元的年股息，预计未来的派息比率为 28.5%。</p>
<h2>史密斯与纳菲 SNATS 价格表现</h2>
<p>在周五的午盘交易中，NYSE SNN 下跌 0.60 美元，跌至 34.25 美元。该公司的股票交易量为 414,074 股，而其平均交易量为 955,770 股。公司当前比率为 2.57，速动比率为 1.40，债务与股本比率为 0.60。史密斯与纳菲 SNATS 的 52 周低点为 23.91 美元，52 周高点为 38.79 美元。该股票的 50 日简单移动平均线为 34.40 美元，200 日简单移动平均线为 34.95 美元。</p>
<h2>史密斯与纳菲 SNATS 的机构交易</h2>
<ul>
<li>外科中心、医疗科技股票因手术需求积压而上涨</li>
</ul>
<p>一些对冲基金最近调整了对 SNN 的持股。Garner Asset Management Corp 在第四季度购买了史密斯与纳菲 SNATS 的新股份，价值约 27,000 美元。Arax Advisory Partners 在第四季度将其在史密斯与纳菲 SNATS 的股份增加了 142.6%。Arax Advisory Partners 现在拥有 968 股该医疗设备提供商的股票，价值 32,000 美元，此前在上个季度又收购了 569 股。Advisors Asset Management Inc.在第四季度购买了史密斯与纳菲 SNATS 的新头寸，价值约 36,000 美元。Caitong International Asset Management Co. Ltd 在第三季度收购了史密斯与纳菲 SNATS 的新股份，估计价值约 41,000 美元。最后，瑞银资产管理（UBS AM）作为瑞银资产管理美洲有限公司的一个独立业务单位，在第四季度收购了史密斯与纳菲 SNATS 的新头寸，价值约 43,000 美元。对冲基金和其他机构投资者持有该公司 25.64% 的股份。</p>
<h2>关于史密斯与纳菲 SNATS</h2>
<p>（获取免费报告）</p>
<p>史密斯与纳菲 plc 是一家全球医疗技术公司，专注于先进外科设备、骨科重建植入物、创伤和四肢产品、运动医学解决方案以及伤口护理疗法的设计、开发和制造。该公司成立于 1856 年，位于英国赫尔，通过有机创新和战略收购不断发展，提供广泛的产品组合，以满足关节置换、微创手术和伤口愈合等患者需求。</p>
<ul>
<li>三家医疗保健股息支付者，价格增长显著</li>
</ul>
<p>在其骨科业务中，史密斯与纳菲提供髋关节和膝关节置换系统、模块化关节修复植入物以及骨修复的生物解决方案。</p>
<h2>进一步阅读</h2>
<ul>
<li>五只我们更看好的股票，胜过史密斯与纳菲 SNATS</li>
<li>BNZI 在 Zacks 买入评级中脱颖而出。盈利动能和分析师升级一致</li>
<li>用这四个简单步骤 “防止” 你的银行账户受到影响</li>
<li>一位前 CIA 特工对即将到来的崩溃的看法</li>
<li>你的名字尚未在我们的保护名单上</li>
<li>今年哪些费用可以从资本利得税中扣除？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/DividendChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNOTg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/DividendChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNOTg"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在史密斯与纳菲 SNATS 吗？</h2>
<p>在考虑投资史密斯与纳菲 SNATS 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄推荐给客户的股票，以便在更广泛的市场注意到之前购买……而史密斯与纳菲 SNATS 并不在名单上。</p>
<p>虽然史密斯与纳菲 SNATS 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

<p>史密斯与内甫 SNATS, Inc.（纽约证券交易所代码：SNN）宣布每股派息 0.48 美元，将于 5 月 27 日支付给截至 3 月 27 日的股东。这代表着 281.0% 的收益率。该公司的派息比率为 26.0%，表明其股息由盈利良好覆盖。分析师预计明年的每股盈利为 2.00 美元，支持股息的可持续性。该股票目前交易价格为 34.25 美元，52 周范围为 23.91 美元至 38.79 美元</p>

<p><strong>Smith &amp; Nephew SNATS, Inc.</strong> (NYSE:SNN - Get Free Report) declared a dividend on Thursday, March 5th. Shareholders of record on Friday, March 27th will be paid a dividend of 0.482 per share by the medical equipment provider on Wednesday, May 27th. This represents a dividend yield of 281.0%. The ex-dividend date is Friday, March 27th.</p>
<div class="lb-trans"><p><strong>史密斯与纳菲 SNATS, Inc.</strong> (NYSE:SNN - 获取免费报告) 于 3 月 5 日（星期四）宣布派发股息。3 月 27 日（星期五）登记在册的股东将于 5 月 27 日（星期三）获得每股 0.482 的股息。这代表着 281.0% 的股息收益率。除息日期为 3 月 27 日（星期五）。</p>
</div><p>Get <strong>Smith &amp; Nephew SNATS</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>史密斯与纳菲 SNATS</strong> 的提醒：</p>
</div><ul>
<li>Santa Rally comes early for these stocks</li>
</ul>
<div class="lb-trans"><ul>
<li>圣诞行情提前到来，这些股票受益</li>
</ul>
</div><p>Smith &amp; Nephew SNATS has raised its dividend payment by an average of 0.0%annually over the last three years. Smith &amp; Nephew SNATS has a payout ratio of 26.0% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Smith &amp; Nephew SNATS to earn $2.00 per share next year, which means the company should continue to be able to cover its $0.57 annual dividend with an expected future payout ratio of 28.5%.</p>
<div class="lb-trans"><p>史密斯与纳菲 SNATS 在过去三年中平均每年提高股息支付 0.0%。史密斯与纳菲 SNATS 的派息比率为 26.0%，表明其股息得到了足够的盈利支持。研究分析师预计史密斯与纳菲 SNATS 明年的每股收益为 2.00 美元，这意味着公司应该能够继续覆盖其 0.57 美元的年股息，预计未来的派息比率为 28.5%。</p>
</div><h2>Smith &amp; Nephew SNATS Price Performance</h2>
<div class="lb-trans"><h2>史密斯与纳菲 SNATS 价格表现</h2>
</div><p>NYSE SNN traded down $0.60 during mid-day trading on Friday, hitting $34.25. The company's stock had a trading volume of 414,074 shares, compared to its average volume of 955,770. The company has a current ratio of 2.57, a quick ratio of 1.40 and a debt-to-equity ratio of 0.60. Smith &amp; Nephew SNATS has a 52-week low of $23.91 and a 52-week high of $38.79. The stock's fifty day simple moving average is $34.40 and its two-hundred day simple moving average is $34.95.</p>
<div class="lb-trans"><p>在周五的午盘交易中，NYSE SNN 下跌 0.60 美元，跌至 34.25 美元。该公司的股票交易量为 414,074 股，而其平均交易量为 955,770 股。公司当前比率为 2.57，速动比率为 1.40，债务与股本比率为 0.60。史密斯与纳菲 SNATS 的 52 周低点为 23.91 美元，52 周高点为 38.79 美元。该股票的 50 日简单移动平均线为 34.40 美元，200 日简单移动平均线为 34.95 美元。</p>
</div><h2>Institutional Trading of Smith &amp; Nephew SNATS</h2>
<div class="lb-trans"><h2>史密斯与纳菲 SNATS 的机构交易</h2>
</div><ul>
<li>Surgical Centers, Med-Tech Stocks Up On Pent-Up Surgical Demand</li>
</ul>
<div class="lb-trans"><ul>
<li>外科中心、医疗科技股票因手术需求积压而上涨</li>
</ul>
</div><p>A number of hedge funds have recently modified their holdings of SNN. Garner Asset Management Corp purchased a new stake in shares of Smith &amp; Nephew SNATS during the 4th quarter worth about $27,000. Arax Advisory Partners boosted its stake in shares of Smith &amp; Nephew SNATS by 142.6% during the 4th quarter. Arax Advisory Partners now owns 968 shares of the medical equipment provider's stock worth $32,000 after acquiring an additional 569 shares in the last quarter. Advisors Asset Management Inc. bought a new position in shares of Smith &amp; Nephew SNATS in the fourth quarter worth about $36,000. Caitong International Asset Management Co. Ltd acquired a new stake in Smith &amp; Nephew SNATS in the 3rd quarter valued at approximately $41,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new position in shares of Smith &amp; Nephew SNATS during the fourth quarter worth approximately $43,000. Hedge funds and other institutional investors own 25.64% of the company's stock.</p>
<div class="lb-trans"><p>一些对冲基金最近调整了对 SNN 的持股。Garner Asset Management Corp 在第四季度购买了史密斯与纳菲 SNATS 的新股份，价值约 27,000 美元。Arax Advisory Partners 在第四季度将其在史密斯与纳菲 SNATS 的股份增加了 142.6%。Arax Advisory Partners 现在拥有 968 股该医疗设备提供商的股票，价值 32,000 美元，此前在上个季度又收购了 569 股。Advisors Asset Management Inc.在第四季度购买了史密斯与纳菲 SNATS 的新头寸，价值约 36,000 美元。Caitong International Asset Management Co. Ltd 在第三季度收购了史密斯与纳菲 SNATS 的新股份，估计价值约 41,000 美元。最后，瑞银资产管理（UBS AM）作为瑞银资产管理美洲有限公司的一个独立业务单位，在第四季度收购了史密斯与纳菲 SNATS 的新头寸，价值约 43,000 美元。对冲基金和其他机构投资者持有该公司 25.64% 的股份。</p>
</div><h2>About Smith &amp; Nephew SNATS</h2>
<div class="lb-trans"><h2>关于史密斯与纳菲 SNATS</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Smith &amp; Nephew plc is a global medical technology company specializing in the design, development and manufacture of advanced surgical devices, orthopaedic reconstruction implants, trauma and extremities products, sports medicine solutions and wound care therapies. Founded in 1856 in Hull, United Kingdom, the company has grown through both organic innovation and strategic acquisitions to offer a broad portfolio that addresses patient needs across joint replacement, minimally invasive surgery and wound healing.</p>
<div class="lb-trans"><p>史密斯与纳菲 plc 是一家全球医疗技术公司，专注于先进外科设备、骨科重建植入物、创伤和四肢产品、运动医学解决方案以及伤口护理疗法的设计、开发和制造。该公司成立于 1856 年，位于英国赫尔，通过有机创新和战略收购不断发展，提供广泛的产品组合，以满足关节置换、微创手术和伤口愈合等患者需求。</p>
</div><ul>
<li>3 Healthcare Dividend Payers With Big Price Growth</li>
</ul>
<div class="lb-trans"><ul>
<li>三家医疗保健股息支付者，价格增长显著</li>
</ul>
</div><p>In its orthopaedics business, Smith &amp; Nephew provides hip and knee replacement systems, modular joint revision implants and biologic solutions for bone repair.</p>
<div class="lb-trans"><p>在其骨科业务中，史密斯与纳菲提供髋关节和膝关节置换系统、模块化关节修复植入物以及骨修复的生物解决方案。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Smith &amp; Nephew SNATS</li>
<li>BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align</li>
<li>“Fed Proof” Your Bank Account with THESE 4 Simple Steps</li>
<li>What a Former CIA Agent Knows About the Coming Collapse</li>
<li>Your name isn't on our protected list yet</li>
<li>What Expenses Can Be Deducted From Capital Gains Tax This Year?</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过史密斯与纳菲 SNATS</li>
<li>BNZI 在 Zacks 买入评级中脱颖而出。盈利动能和分析师升级一致</li>
<li>用这四个简单步骤 “防止” 你的银行账户受到影响</li>
<li>一位前 CIA 特工对即将到来的崩溃的看法</li>
<li>你的名字尚未在我们的保护名单上</li>
<li>今年哪些费用可以从资本利得税中扣除？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/DividendChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNOTg" alt="" original-src="https://www.marketbeat.com/scripts/DividendChart.ashx?Prefix=NYSE&amp;Symbol=SNN"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Smith &amp; Nephew SNATS Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在史密斯与纳菲 SNATS 吗？</h2>
</div><p>Before you consider Smith &amp; Nephew SNATS, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑投资史密斯与纳菲 SNATS 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Smith &amp; Nephew SNATS wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄推荐给客户的股票，以便在更广泛的市场注意到之前购买……而史密斯与纳菲 SNATS 并不在名单上。</p>
</div><p>While Smith &amp; Nephew SNATS currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然史密斯与纳菲 SNATS 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Smith & Nephew SNATS, Inc. (NYSE:SNN) 将发放 0.48 美元的股息